Semler Scientific
Sandy A. is an experienced professional in product management, currently serving as the Director of Product Management at Semler Scientific® since April 2021, after previously holding the position of Sr Product Manager. Prior experience includes a comprehensive tenure at Inmar Intelligence from March 2010 to April 2021, where Sandy A. held various roles including Product Manager for Consumer Services and Healthcare, Sales Solutions Expert, and Business Intelligence Analyst. Earlier roles include Reimbursement Project and Data Analyst at Medcost and Contract and Rebate Analyst at Henry Schein. Sandy A. holds a Bachelor of Arts degree in History and Business Administration from Fordham University, demonstrating a strong educational background supportive of professional expertise.
This person is not in any offices
Semler Scientific
1 followers
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and FDA- cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care.